Open AccessChemotherapy Is Associated With Improved Survival in Adult Patients With Primary Extremity Synovial Sarcoma
Author(s) -
Fritz C. Eilber,
Murray F. Brennan,
Frederick R. Eilber,
Jeffery J. Eckardt,
Stephen R. Grobmyer,
Elyn Riedel,
Charles Forscher,
Robert G. Maki,
Samuel Singer
Publication year - 2007
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/01.sla.0000262787.88639.2b
Subject(s) - medicine , ifosfamide , synovial sarcoma , chemotherapy , sarcoma , surgery , primary tumor , oncology , gastroenterology , cancer , metastasis , pathology , cisplatin
To determine if ifosfamide-based chemotherapy (IF) offers a survival benefit to adult patients with primary extremity synovial sarcoma.